Piper Sandler started coverage on shares of Zura Bio (NASDAQ:ZURA – Free Report) in a research report sent to investors on Friday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $26.00 price target on the stock. Separately, Oppenheimer reaffirmed an outperform rating and set a $16.00 price target (down previously from $17.00) […]